Skip to main content
. 2019 Jun 2;20(11):2711. doi: 10.3390/ijms20112711
OA Osteoarthritis
iPSCs Induced Pluripotent Stem Cells
3D Three-dimensional
ECM Extracellular Matrix
ACI Autologous Chondrocyte Implantation
MSC Mesenchymal Stromal Cells
PSC Pluripotent Stem Cells
hESC Human Embryonic Stem Cells
FBS Fetal Bovine Serum
SOX2 SRY (sex determining region Y)-box 2
OCT4 Octamer-binding transcription factor 4
CDH1 Cadherin-1 (E-cadherin)
TGF-β3 Transforming Growth Factor beta 3
EB Embryoid Body
ChD Chondrogenic Differentiation
ChM Chondrogenic Medium
PHDF Primary Human Dermal Fibroblast
RT-qPCR Reverse Transcriptase quantitative Polymerase Chain Reaction
FGFR3 Fibroblast Growth Factor Receptor 3
SMAD3 SMAD Family Member 3
CDH2 Cadherin-2 (N-cadherin)
NCAM1 Neural Cell Adhesion Molecule 1
COL1A2 Collagen type 1 alpha 2 chain
SOX9 SRY (sex determining region Y)-box 9
COL2A1 Collagen type 2 alpha 1 chain
ACAN Aggrecan
GAGs Glycosaminoglycans
KSR Knock-out Serum Replacement
SCID Severe Combined Immunodeficiency
DMEM Dulbecco Modified Eagle Medium
PBS Phosphate Buffered Saline
EDTA Ethylenediaminetetraacetic acid
NEAA Non-essential Amino Acids
B2M Beta-2-Microglobulin
DAPI 4′,6-diamidino-2-phenylindole